Printer Friendly

Browse Phospholipases topic

Health aspects subtopic


1-14 out of 14 article(s)
Title Author Type Date Words
Interactions between Cytosolic Phospholipase A2 Activation and Mitochondrial Reactive Oxygen Species Production in the Development of Ventilator-Induced Diaphragm Dysfunction. Zhou, Xian-Long; Wei, Xiao-Jun; Li, Shao-Ping; Liu, Rui-Ning; Yu, Ming-Xia; Zhao, Yan Apr 30, 2019 6385
"CLUPS": A New Culture Medium for the Axenic Growth of Entamoeba histolytica. Gonzalez-Salazar, F.; Meester, I.; De La Garza, F.J. Guzman; De La Garza- Salinas, L.H.; Sampayo-Rey Jan 1, 2018 4127
Relationship between the Antifungal Susceptibility Profile and the Production of Virulence-Related Hydrolytic Enzymes in Brazilian Clinical Strains of Candida glabrata. Figueiredo-Carvalho, Maria Helena Galdino; Ramos, Livia de Souza; Barbedo, Leonardo Silva; de Olivei Report Jan 1, 2017 8281
Reminiscence of phospholipase B in Penicillium notatum. Saito, Kunihiko Report Sep 1, 2014 8415
Protective effect of cytosolic phospholipase A2 inhibition against inflammation and degeneration by promoting regulatory T cells in rats with experimental autoimmune encephalomyelitis. Yang, Dan; Ji, Hong-Fei; Zhang, Xue-Mei; Yue, Hui; Lin, Lin; Ma, Yu-Yan; Huang, Xiang-nan; Fu, Jin; Report Jan 1, 2014 4284
Clinical utility of lipoprotein-associated phospholipase [A.sub.2] for cardiovascular disease prediction in a multiethnic cohort of women. Cook, Nancy R.; Paynter, Nina P.; Manson, JoAnn E.; Martin, Lisa W.; Robinson, Jennifer G.; Wasserth Report Sep 1, 2012 9001
Expression levels of virulence factors with up-regulation of hemolytic phospholipase C in biofilm-forming pseudomonas aeruginosa at a tertiary care center. Zahreddine, Lama T.; Khairallah, Marie Therese; Sabra, Ahmad H.; Baroud, Maysa; Hadi, Usamah; Matar, Report Jun 1, 2012 4646
Lipoprotein-associated phospholipase [A.sub.2] measurements: Mass, activity, but little productivity. Stein, Evan A. Editorial May 1, 2012 2763
Relationship of lipoprotein-associated phospholipase [A.sub.2] mass and activity with incident vascular events among primary prevention patients allocated to placebo or to statin therapy: an analysis from the JUPITER trial. Ridker, Paul M.; MacFadyen, Jean G.; Wolfert, Robert L.; Koenig, Wolfgang Report May 1, 2012 7600
Isolation of Cryptococcus neoformans in dry droppings of captive birds in Santiago, Chile. Gonzalez-Hein, Gisela; Gonzalez-Hein, Jaime; Jarabran, Maria C. Diaz Report Sep 1, 2010 5959
Relationship among plasma secretory phospholipase [A.sub.2], oxidized low density lipoprotein & paraoxonase activities in hypertensive subjects treated with angiotensin converting enzyme inhibitors. Konukoglu, Dildar; Firtina, Sinem; Serin, Ozden; Cavusoglu, Coskun Report Apr 1, 2009 3527
Identifying the vulnerable patient with rupture-prone plaque. Clinical report Nov 1, 2008 269
Enhanced expression of LP-PLA2 and lysophosphatidylcholine in symptomatic carotid atherosclerotic plaques. Clinical report Nov 1, 2008 291
Promising new biomarker for heart disease risk. (For Population Most in Need). Jancin, Bruce Jul 1, 2003 568

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters